Clinical Trial Update: TMS Stimulation and Cognitive Training in Alzheimer Patients [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating transcranial magnetic stimulation (TMS) with cognitive training for patients with mild-to-moderate Alzheimer disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Snippet

Sponsor: Neuronix Ltd | Conditions: Alzheimer Disease, Mild to Moderate | Phase 1 | Status: COMPLETED